C O M M U N I C A T I O N S
Table 2. Diastereo- and Enantioselective Conjugate Addition of
Trisubstituted Cyanoacetate Derivatives
accessible in enantioenriched form. Synthetic applications of these
products include the preparation of enantiomerically enriched
piperidines, as exemplified by an expedient asymmetric catalytic
synthesis of (-)-paroxetine. Studies are underway to expand the
scope and synthetic utility of this new reaction, as well as to glean
insight into its mechanism.
Acknowledgment. This work was supported by the NIH (GM-
43214). We are grateful to Dr. R. Staples for carrying out the X-ray
structural analyses.
product
R
R′
time
yield (%)a
ee (%)b
drc
5ad,f
5bd,f
5cd,g
5dd,g
n-Pr
n-Pr
n-Pr
n-Pr
Ph
19 h
15 h
38 h
51 h
98
96
94
79
97
98
95
95
14:1
35:1
6:1
Supporting Information Available: Complete experimental pro-
cedures, characterization data, and chiral chromatographic analyses of
racemic and enantiomerically enriched products (PDF and CIF). This
m-CF3C6H4
p-MeOC6H4
14:1
5ed,g
5fd,f
n-Pr
Me
i-Bu
Me
n-Pr
i-Bu
Ph
2-thiophenyl
Ph
4 d
76
95
96
74
92
89
68
91
86
96
92
91
97
96
14:1
5:1
References
24 h
24 h
26 h
23 h
60 h
54 h
5gd,g
6ae,f
6be,g
6ce,g
6de,h
Ph
16:1
10:1
14:1
13:1
20:1
(1) For reviews, see: (a) Tomioka, K.; Nagaoka, Y.; Yamaguchi, M. In
ComprehensiVe Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A.,
Yamamoto, H., Eds.; Springer: Berlin, 1999; Vol. 3, Chapters 31.1 and
31.2. (b) Krause, N.; Hoffmann-Ro¨der, A. Synthesis 2001, 171-196.
(2) Enantioselective conjugate addition of malonates to (a) acyclic enals and
enones: Yamaguchi, M.; Shiraishi, T.; Hirama, M. Angew. Chem., Int.
Ed. Engl. 1993, 32, 1173-1175. Halland, N.; Aburel, P. S.; Jørgensen,
K. A. Angew. Chem., Int. Ed. 2003, 42, 661-665. (b) chalcone: End,
N.; Macko, L.; Zehnder, M.; Pfaltz, A. Chem.-Eur. J. 1998, 4, 818-824.
(c) Addition of â-dicarbonyl compounds to cyclic enones: Sasai, H.; Arai,
T.; Shibasaki, M. J. Am. Chem. Soc. 1994, 116, 1571-1572. Sasai, H.;
Arai, T.; Satow, Y.; Houk, K. N.; Shibasaki, M. J. Am. Chem. Soc. 1995,
117, 6194-6198. Arai, T.; Sasai, H.; Aoe, K.; Okamura, K.; Date, T.;
Shibasaki, M. Angew. Chem., Int. Ed. Engl. 1996, 35, 104-106.
NHBn
NHBn
NHBn
NHBn
a Isolated yield, after chromatography, from reactions carried out on 0.50
mmol scale. b Of major diastereomer, determined by chiral HPLC. c De-
termined by 1H NMR. d Reaction carried out using (R,R)-1. e Reaction
carried out using (S,S)-1. f Reaction carried out using 2.5 mol % catalyst.
g Reaction carried out using 5.0 mol % catalyst. h Reaction carried out with
10 mol % catalyst and 2.5 equiv of t-BuOH.
(3) Enantioselective conjugate additions of nitroalkanes to (a) N-acylpyra-
zoles: Itoh, K.; Kanemasa, S. J. Am. Chem. Soc. 2002, 124, 13394-
13395. (b) acyclic enones: Halland, N.; Hazell, R. G.; Jørgensen, K. A.
J. Org. Chem. 2002, 67, 8331-8338. (c) chalcones: Funabashi, K.; Saida,
Y.; Kanai, M.; Arai, T.; Sasi, H.; Shibasaki, M. Tetrahedron Lett. 1998,
39, 7557-7558.
Scheme 1. Regioselective Cleavage of Imides 3b and 4ba
(4) For enantioselective conjugate additions to R,â-unsaturated imides of
general structure 2, see (a) HN3: Myers, J. K.; Jacobsen, E. N. J. Am.
Chem. Soc. 1999, 121, 8959-8960. (b) HCN: Sammis, G. M.; Jacobsen,
E. N. J. Am. Chem. Soc. 2003, 125, 4442-4443. (c) thiols: Chen, Q.;
Jacobsen, E. N., manuscript in preparation. (d) salen-Red-Al-catalyzed
Michael additions to ketones have been described: Jha, S. C.; Joshi, N.
N. Tetrahedron: Asymmetry 2001, 12, 2463-2466.
(5) The screen included â-ketoesters, malonates, nitroalkanes, and sulfones;
nitrile-substituted substrates proved uniquely effective in reactions
catalyzed by 1.
(6) Catalyst 1 is a bench-stable complex prepared by partial hydrolysis of
the corresponding (salen)AlMe derivative. (a) Rutherford, D.; Atwood,
D. A. Organometallics 1996, 15, 4417-4422. For related complexes,
see: (b) Dzugan, S. J.; Goedken, V. L. Inorg. Chem. 1986, 25, 2858. (c)
Gurian, P. L.; Cheatham, L. K.; Ziller, J. W.; Barron, A. R. J. Chem.
Soc., Dalton Trans. 1991, 1449-1456.
a R ) p-FC6H4, R′ ) Me, allyl. For reagents and conditions, see
Supporting Information.
(7) The origin of the rate acceleration imparted by tert-butyl alcohol has not
been ascertained. However, promotion of turnover of aluminum enolate
intermediates represents a likely role. For a general discussion of the use
of achiral additives in asymmetric catalysis: Vogl, E. M.; Gro¨ger, H.;
Shibasaki, M. Angew. Chem., Int. Ed. 1999, 38, 1570-1577.
(8) For other examples, see: (a) Hermann, K.; Wynberg, H. J. Org. Chem.
1979, 44, 2238-2244. (b) Sasai, H.; Emori, E.; Arai, T.; Shibasaki, M.
Tetrahedron Lett. 1996, 37, 5561-5564. (c) Hamashima, Y.; Hotta, D.;
Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 11240-11241. (d) Sawamura,
M.; Hamashima, H.; Ito, Y. J. Am. Chem. Soc. 1992, 114, 8295-8296.
(e) Sawamura, M.; Hamashima, H.; Shinoto, H.; Ito, Y. Tetrahedron Lett.
1995, 36, 6479-6482. (f) Review: Christoffers, J.; Baro, A. Angew.
Chem., Int. Ed. 2003, 42, 1688-1690.
carboxylic acids6a (e.g., 8), esters10 (e.g., 9a, b), Weinreb amides11
(e.g., 10), and N-benzyl amides (e.g., 11) are obtained without loss
of enantiopurity. Reduction of the nitrile group results in intramo-
lecular aminolysis, delivering the δ-lactam 12 as a 2:1 mixture of
diastereomers. Such δ-lactams are useful intermediates for the
synthesis of piperidines, ubiquitous structures in natural products
and pharmaceutically active compounds.
As an illustration of the utility of the latter methodology, paroxe-
tine (Paxil), a serotonin reuptake inhibitor used widely for the
treatment of anxiety, was prepared from 12 (R ) 4-FC6H4) in six
steps, following a synthesis developed at Sumigo Fine Chemicals.12
Starting with 2b and through the intermediacy of 4b obtained in
96% ee by recrystallization from ethanol (77% recovery), (-)-
paroxetine was obtained in a total yield of 47% over seven steps.13,14
We have demonstrated that the aluminum complex 1 is an
efficient catalyst for the conjugate addition of di- and trisubstituted
nitriles to a wide range of acyclic alkyl- and aryl-substituted R,â-
unsaturated imides. This new methodology provides access to
multifunctional compounds that, to date, have not been readily
(9) Krapcho, A. P. Synthesis 1982, 805-822, 893-913.
(10) For the Sm(OTf)3-catalyzed regioselective methanolysis of imides, see:
Evans, D. A.; Trotter, B. W.; Coleman, P. J.; Coˆte´, B.; Dias, L. C.;
Rajapakse, H. A.; Tyler, A. N. Tetrahedron 1999, 55, 8671-8726.
(11) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815-3818.
(12) The Sumigo route incorporates a racemic conjugate addition and a late
stage resolution. Sugi, K.; Itaya, N.; Katsura, T.; Igi, M.; Yamazaki, S.;
Ishibashi, T.; Yamaoka, T.; Kawada, Y.; Tagami, Y.; Otsuki, M.; Oshima,
T. Chem. Pharm. Bull. 2000, 48, 529-536.
(13) All characterization data, including optical rotation, were in agreement
with literature values (ref 12).
(14) For a prior asymmetric catalytic synthesis of paroxetine employing an
enzymatic desymmetrization as the key step, see: Yu, M.; Lantos, I.; Peng,
Z.; Yu, J.; Cacchio, T. Tetrahedron Lett. 2000, 41, 5647-5651. For other
syntheses of paroxetine, see references therein.
JA037177O
9
J. AM. CHEM. SOC. VOL. 125, NO. 37, 2003 11205